Knoll Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History
Knoll Capital Management, LLC
- $150 Million
- Q1 2025
A detailed history of Knoll Capital Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 5,475,516 shares of ALDX stock, worth $27.5 Million. This represents 21.03% of its overall portfolio holdings.
Number of Shares
5,475,516
Previous 5,475,516
-0.0%
Holding current value
$27.5 Million
Previous $27.3 Million
15.23%
% of portfolio
21.03%
Previous 17.63%
Shares
13 transactions
Others Institutions Holding ALDX
# of Institutions
141Shares Held
38.8MCall Options Held
620KPut Options Held
435K-
Perceptive Advisors LLC New York, NY9.28MShares$46.7 Million2.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$18.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.2 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$8.8 Million2.26% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.23MShares$6.2 Million0.18% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $293M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...